Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

RISEDRONATE SODIUM

RISEDRONATE SODIUM

Standard Dose
75MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview RISEDRONATE SODIUM is listed in Drugs@FDA under application 200477 (ANDA).

Marketing status: Discontinued Active ingredient RISEDRONATE SODIUM Form and strength TABLET;ORAL - 75MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview RISEDRONATE SODIUM is listed in Drugs@FDA under application 200477 (ANDA). Marketing status: Discontinued Active ingredient RISEDRONATE SODIUM Form and strength TABLET;ORAL - 75MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.